Skip to main content
Top
Published in: Medical Gas Research 1/2014

Open Access 01-12-2014 | Research

Supplemental oxygen delivery to suspected stroke patients in pre hospital and emergency department settings

Authors: Yu-Feng Yvonne Chan, Maya Katz, Ari Moskowitz, Steven R Levine, Lynne D Richardson, Stanley Tuhrim, Kevin Chason, Kelly Barsan- Silverman, Aneesh Singhal

Published in: Medical Gas Research | Issue 1/2014

Login to get access

Abstract

Background

Recent data suggests that high-flow oxygen started promptly after stroke symptom onset salvages ischemic brain tissue. We investigated the consistency of oxygen delivery to suspected stroke patients in the pre-hospital (PH) and Emergency Department (ED) settings, and associated adverse events (AEs).

Methods

We retrospectively reviewed pre-hospital call reports of suspected stroke patients transported by our institution’s paramedics. We extracted data on oxygen delivery in the PH and ED settings, demographics, Glasgow Coma Scale score (GCS), final diagnosis, and selected AEs (mortality, seizures, worsening neurological status, new infarction, and post-ischemic hemorrhage). Patients were grouped according to ED oxygen delivery: none, low-flow (2-4 L/min), and high-flow (10-15 L/min).

Results

Oxygen delivery was documented in 84% of 366 stroke transports, with 98% receiving 10-15 L/min. Our hospital received 164 patients. Oxygen delivery in the ED was documented in 150 patients, with 38% receiving none, 47% low-flow, and 15% high-flow oxygen. There were no instances of oxygen refusal, premature termination, or technical difficulties. Advanced age and low GCS predicted the use of higher flow rates. High-flow oxygen was more frequently administered to patients with symptom onset < 3 hours, and those with intracerebral hemorrhage (ICH), hypoxic-ischemic encephalopathy (HIE) or seizures (p < 0.001). More patients receiving high-flow oxygen were documented to have an AE (p = 0.02), however the low- and no-oxygen groups more frequently had multiple AEs (p = 0.01). The occurrence of AEs was predicted by the diagnosis of ICH/HIE/seizures (p = 0.013) and acute ischemic stroke (AIS)/transient ischemic attack (TIA) (p = 0.009), but not by the amount of oxygen.

Conclusions

Suspected stroke patients routinely receive 10–15 L/min oxygen in the ambulance however in the ED there is wide variability due to factors such as clinical severity. Oxygen delivery appears safe in the PH and ED settings.
Literature
1.
go back to reference Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H: American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013, 44 (3): 870-947. 10.1161/STR.0b013e318284056a.CrossRefPubMed Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H: American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013, 44 (3): 870-947. 10.1161/STR.0b013e318284056a.CrossRefPubMed
2.
go back to reference Singhal AB: Oxygen therapy in stroke: past, present, and future. Int J Stroke. 2006, 1 (4): 191-200. 10.1111/j.1747-4949.2006.00058.x.CrossRefPubMed Singhal AB: Oxygen therapy in stroke: past, present, and future. Int J Stroke. 2006, 1 (4): 191-200. 10.1111/j.1747-4949.2006.00058.x.CrossRefPubMed
3.
go back to reference Qi Z, Liu W, Luo Y, Ji X, Liu KJ: Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke. Med Gas Res. 2013, 3 (1): 2-10.1186/2045-9912-3-2.PubMedCentralCrossRefPubMed Qi Z, Liu W, Luo Y, Ji X, Liu KJ: Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke. Med Gas Res. 2013, 3 (1): 2-10.1186/2045-9912-3-2.PubMedCentralCrossRefPubMed
4.
go back to reference Veltkamp R, Sun L, Herrmann O, Wolferts G, Hagmann S, Siebing DA, Marti HH, Veltkamp C, Schwaninger M: Oxygen therapy in permanent brain ischemia: potential and limitations. Brain Res. 2006, 1107 (1): 185-191. 10.1016/j.brainres.2006.05.108.CrossRefPubMed Veltkamp R, Sun L, Herrmann O, Wolferts G, Hagmann S, Siebing DA, Marti HH, Veltkamp C, Schwaninger M: Oxygen therapy in permanent brain ischemia: potential and limitations. Brain Res. 2006, 1107 (1): 185-191. 10.1016/j.brainres.2006.05.108.CrossRefPubMed
5.
go back to reference Zhang JH, Lo T, Mychaskiw G, Colohan A: Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology. 2005, 12 (1): 63-77. 10.1016/j.pathophys.2005.01.003.CrossRefPubMed Zhang JH, Lo T, Mychaskiw G, Colohan A: Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology. 2005, 12 (1): 63-77. 10.1016/j.pathophys.2005.01.003.CrossRefPubMed
6.
go back to reference Henninger N, Fisher M: Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment. Cerebrovasc Dis. 2006, 21 (1–2): 134-136.CrossRefPubMed Henninger N, Fisher M: Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment. Cerebrovasc Dis. 2006, 21 (1–2): 134-136.CrossRefPubMed
7.
go back to reference Rink C, Gnyawali S, Peterson L, Khanna S: Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke. Antioxid Redox Signal. 2011, 14 (10): 1777-1785. 10.1089/ars.2011.3930.PubMedCentralCrossRefPubMed Rink C, Gnyawali S, Peterson L, Khanna S: Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke. Antioxid Redox Signal. 2011, 14 (10): 1777-1785. 10.1089/ars.2011.3930.PubMedCentralCrossRefPubMed
8.
go back to reference Shin HK, Dunn AK, Jones PB, Boas DA, Lo EH, Moskowitz MA, Ayata C: Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain. 2007, 130 (Pt 6): 1631-1642.PubMedCentralCrossRefPubMed Shin HK, Dunn AK, Jones PB, Boas DA, Lo EH, Moskowitz MA, Ayata C: Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain. 2007, 130 (Pt 6): 1631-1642.PubMedCentralCrossRefPubMed
9.
go back to reference Singhal AB, Ratai E, Benner T, Vangel M, Lee V, Koroshetz WJ, Schaefer PW, Sorensen AG, Gonzalez RG: Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke. Stroke. 2007, 38 (10): 2851-2854. 10.1161/STROKEAHA.107.487280.CrossRefPubMed Singhal AB, Ratai E, Benner T, Vangel M, Lee V, Koroshetz WJ, Schaefer PW, Sorensen AG, Gonzalez RG: Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke. Stroke. 2007, 38 (10): 2851-2854. 10.1161/STROKEAHA.107.487280.CrossRefPubMed
10.
go back to reference Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, Buonanno FS, Gonzalez RG, Sorensen AG: A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005, 36 (4): 797-802. 10.1161/01.STR.0000158914.66827.2e.CrossRefPubMed Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, Buonanno FS, Gonzalez RG, Sorensen AG: A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005, 36 (4): 797-802. 10.1161/01.STR.0000158914.66827.2e.CrossRefPubMed
11.
go back to reference Chiu EH, Liu CS, Tan TY, Chang KC: Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Arch Neurol. 2006, 63 (5): 741-744. 10.1001/archneur.63.5.741.CrossRefPubMed Chiu EH, Liu CS, Tan TY, Chang KC: Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Arch Neurol. 2006, 63 (5): 741-744. 10.1001/archneur.63.5.741.CrossRefPubMed
12.
go back to reference Kim HY, Singhal AB, Lo EH: Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol. 2005, 57 (4): 571-575. 10.1002/ana.20430.CrossRefPubMed Kim HY, Singhal AB, Lo EH: Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol. 2005, 57 (4): 571-575. 10.1002/ana.20430.CrossRefPubMed
13.
go back to reference Wu O, Lu J, Mandeville JB, Murata Y, Egi Y, Dai G, Marota JJ, Diwan I, Dijkhuizen RM, Kwong KK, Lo EH, Singhal AB: Dynamic functional cerebral blood volume responses to normobaric hyperoxia in acute ischemic stroke. J Cereb Blood Flow Metab. 2012, 32 (9): 1800-1809. 10.1038/jcbfm.2012.87.PubMedCentralCrossRefPubMed Wu O, Lu J, Mandeville JB, Murata Y, Egi Y, Dai G, Marota JJ, Diwan I, Dijkhuizen RM, Kwong KK, Lo EH, Singhal AB: Dynamic functional cerebral blood volume responses to normobaric hyperoxia in acute ischemic stroke. J Cereb Blood Flow Metab. 2012, 32 (9): 1800-1809. 10.1038/jcbfm.2012.87.PubMedCentralCrossRefPubMed
14.
go back to reference Henninger N, Bouley J, Nelligan JM, Sicard KM, Fisher M: Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 2007, 27 (9): 1632-1642. 10.1038/sj.jcbfm.9600463.CrossRefPubMed Henninger N, Bouley J, Nelligan JM, Sicard KM, Fisher M: Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 2007, 27 (9): 1632-1642. 10.1038/sj.jcbfm.9600463.CrossRefPubMed
15.
go back to reference Chen CH, Chen SY, Wang V, Chen CC, Wang KC, Chen CH, Liu YC, Lu KC, Yip PK, Ma WY, Liu CC: Effects of repetitive hyperbaric oxygen treatment in patients with acute cerebral infarction: a pilot study. ScientificWorldJournal. 2012, 2012: 694703-PubMedCentralPubMed Chen CH, Chen SY, Wang V, Chen CC, Wang KC, Chen CH, Liu YC, Lu KC, Yip PK, Ma WY, Liu CC: Effects of repetitive hyperbaric oxygen treatment in patients with acute cerebral infarction: a pilot study. ScientificWorldJournal. 2012, 2012: 694703-PubMedCentralPubMed
16.
go back to reference Thom SR: Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol (1985). 2009, 106 (3): 988-995. 10.1152/japplphysiol.91004.2008.CrossRef Thom SR: Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol (1985). 2009, 106 (3): 988-995. 10.1152/japplphysiol.91004.2008.CrossRef
17.
go back to reference Sun L, Wolferts G, Veltkamp R: Oxygen therapy does not increase production and damage induced by reactive oxygen species in focal cerebral ischemia. Neurosci Lett. 2014, 577: 1-5.CrossRefPubMed Sun L, Wolferts G, Veltkamp R: Oxygen therapy does not increase production and damage induced by reactive oxygen species in focal cerebral ischemia. Neurosci Lett. 2014, 577: 1-5.CrossRefPubMed
18.
go back to reference McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985, 312 (3): 159-163. 10.1056/NEJM198501173120305.CrossRefPubMed McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985, 312 (3): 159-163. 10.1056/NEJM198501173120305.CrossRefPubMed
21.
go back to reference Pancioli AM, Bullard MJ, Grulee ME, Jauch EC, Perkis DF: Supplemental oxygen use in ischemic stroke patients: does utilization correspond to need for oxygen therapy?. Arch Intern Med. 2002, 162 (1): 49-52. 10.1001/archinte.162.1.49.CrossRefPubMed Pancioli AM, Bullard MJ, Grulee ME, Jauch EC, Perkis DF: Supplemental oxygen use in ischemic stroke patients: does utilization correspond to need for oxygen therapy?. Arch Intern Med. 2002, 162 (1): 49-52. 10.1001/archinte.162.1.49.CrossRefPubMed
23.
go back to reference Pancioli AM, Bullard MJ, Grulee ME, Jauch EC, Perkis DF: Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2005, 3: CD004954 Pancioli AM, Bullard MJ, Grulee ME, Jauch EC, Perkis DF: Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2005, 3: CD004954
24.
go back to reference Ronning OM, Guldvog B: Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999, 30 (10): 2033-2037. 10.1161/01.STR.30.10.2033.CrossRefPubMed Ronning OM, Guldvog B: Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999, 30 (10): 2033-2037. 10.1161/01.STR.30.10.2033.CrossRefPubMed
25.
go back to reference Zhang JH, Singhal AB, Toole JF: Oxygen therapy in ischemic stroke. Stroke. 2003, 34 (9): e152-e153. 10.1161/01.STR.0000087098.30644.E1. author reply e153-5CrossRefPubMed Zhang JH, Singhal AB, Toole JF: Oxygen therapy in ischemic stroke. Stroke. 2003, 34 (9): e152-e153. 10.1161/01.STR.0000087098.30644.E1. author reply e153-5CrossRefPubMed
Metadata
Title
Supplemental oxygen delivery to suspected stroke patients in pre hospital and emergency department settings
Authors
Yu-Feng Yvonne Chan
Maya Katz
Ari Moskowitz
Steven R Levine
Lynne D Richardson
Stanley Tuhrim
Kevin Chason
Kelly Barsan- Silverman
Aneesh Singhal
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Medical Gas Research / Issue 1/2014
Electronic ISSN: 2045-9912
DOI
https://doi.org/10.1186/2045-9912-4-16

Other articles of this Issue 1/2014

Medical Gas Research 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.